204 related articles for article (PubMed ID: 11410869)
1. Induction of apoptosis by cyclo-oxygenase-2 inhibitor NS398 through a cytochrome C-dependent pathway in esophageal cancer cells.
Li M; Wu X; Xu XC
Int J Cancer; 2001 Jul; 93(2):218-23. PubMed ID: 11410869
[TBL] [Abstract][Full Text] [Related]
2. Induction of apoptosis in colon cancer cells by cyclooxygenase-2 inhibitor NS398 through a cytochrome c-dependent pathway.
Li M; Wu X; Xu XC
Clin Cancer Res; 2001 Apr; 7(4):1010-6. PubMed ID: 11309352
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells.
Sun Y; Tang XM; Half E; Kuo MT; Sinicrope FA
Cancer Res; 2002 Nov; 62(21):6323-8. PubMed ID: 12414664
[TBL] [Abstract][Full Text] [Related]
4. NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells.
Liu XH; Yao S; Kirschenbaum A; Levine AC
Cancer Res; 1998 Oct; 58(19):4245-9. PubMed ID: 9766645
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase (COX) inhibitors induce apoptosis in non-small cell lung cancer through cyclooxygenase independent pathways.
Sánchez-Alcázar JA; Bradbury DA; Pang L; Knox AJ
Lung Cancer; 2003 Apr; 40(1):33-44. PubMed ID: 12660005
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of chemotherapeutic drug-induced apoptosis by a cyclooxygenase-2 inhibitor in hypopharyngeal carcinoma cells.
Peng JP; Liu LT; Chang HC; Hung WC
Cancer Lett; 2003 Nov; 201(2):157-63. PubMed ID: 14607329
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2 level and culture conditions influence NS398-induced apoptosis and caspase activation in lung cancer cells.
Chang HC; Weng CF
Oncol Rep; 2001; 8(6):1321-5. PubMed ID: 11605058
[TBL] [Abstract][Full Text] [Related]
8. The anti-apoptotic effect of leukotriene D4 involves the prevention of caspase 8 activation and Bid cleavage.
Wikström K; Juhas M; Sjölander A
Biochem J; 2003 Apr; 371(Pt 1):115-24. PubMed ID: 12482325
[TBL] [Abstract][Full Text] [Related]
9. COX-2 inhibitor, NS398, enhances Fas-mediated apoptosis via modulation of the PTEN-Akt pathway in human gastric carcinoma cell lines.
Honjo S; Osaki M; Ardyanto TD; Hiramatsu T; Maeta N; Ito H
DNA Cell Biol; 2005 Mar; 24(3):141-7. PubMed ID: 15767780
[TBL] [Abstract][Full Text] [Related]
10. The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis.
Minter HA; Eveson JW; Huntley S; Elder DJ; Hague A
Clin Cancer Res; 2003 May; 9(5):1885-97. PubMed ID: 12738747
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2 inhibitor celecoxib augments chemotherapeutic drug-induced apoptosis by enhancing activation of caspase-3 and -9 in prostate cancer cells.
Dandekar DS; Lopez M; Carey RI; Lokeshwar BL
Int J Cancer; 2005 Jun; 115(3):484-92. PubMed ID: 15688368
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of paclitaxel-induced apoptosis by the specific COX-2 inhibitor, NS398, in epithelial ovarian cancer cells.
Munkarah AR; Genhai Z; Morris R; Baker VV; Deppe G; Diamond MP; Saed GM
Gynecol Oncol; 2003 Mar; 88(3):429-33. PubMed ID: 12648598
[TBL] [Abstract][Full Text] [Related]
13. A selective cyclooxygenase-2 inhibitor, NS398, inhibits cell growth and induces cell cycle arrest in the G2/M phase in human esophageal squamous cell carcinoma cells.
Kase S; Osaki M; Honjo S; Takeda A; Adachi K; Araki K; Ito H
J Exp Clin Cancer Res; 2004 Jun; 23(2):301-7. PubMed ID: 15354416
[TBL] [Abstract][Full Text] [Related]
14. Apo2L/TRAIL differentially modulates the apoptotic effects of sulindac and a COX-2 selective non-steroidal anti-inflammatory agent in Bax-deficient cells.
He Q; Luo X; Huang Y; Sheikh MS
Oncogene; 2002 Sep; 21(39):6032-40. PubMed ID: 12203115
[TBL] [Abstract][Full Text] [Related]
15. Expression of cyclooxygenase-2 (COX-2) in human esophageal cancer and in vitro inhibition by a specific COX-2 inhibitor, NS-398.
Yu HP; Shi LY; Lu WH; Su YH; Li YY; Xu SQ
J Gastroenterol Hepatol; 2004 Jun; 19(6):638-42. PubMed ID: 15151617
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-2 (COX-2) inhibitors sensitize tumor cells specifically to death receptor-induced apoptosis independently of COX-2 inhibition.
Totzke G; Schulze-Osthoff K; Jänicke RU
Oncogene; 2003 Sep; 22(39):8021-30. PubMed ID: 12970750
[TBL] [Abstract][Full Text] [Related]
17. NS398 reduces hypoxia-inducible factor (HIF)-1alpha and HIF-1 activity: multiple-level effects involving cyclooxygenase-2 dependent and independent mechanisms.
Zhong H; Willard M; Simons J
Int J Cancer; 2004 Nov; 112(4):585-95. PubMed ID: 15382039
[TBL] [Abstract][Full Text] [Related]
18. Induction of p27(KIP1) as a mechanism underlying NS398-induced growth inhibition in human lung cancer cells.
Hung WC; Chang HC; Pan MR; Lee TH; Chuang LY
Mol Pharmacol; 2000 Dec; 58(6):1398-403. PubMed ID: 11093779
[TBL] [Abstract][Full Text] [Related]
19. Celecoxib activates a novel mitochondrial apoptosis signaling pathway.
Jendrossek V; Handrick R; Belka C
FASEB J; 2003 Aug; 17(11):1547-9. PubMed ID: 12824303
[TBL] [Abstract][Full Text] [Related]
20. Non-steroidal anti-inflammatory drugs inhibit cellular proliferation and upregulate cyclooxygenase-2 protein expression in endometrial cancer cells.
Gao J; Niwa K; Sun W; Takemura M; Lian Z; Onogi K; Seishima M; Mori H; Tamaya T
Cancer Sci; 2004 Nov; 95(11):901-7. PubMed ID: 15546508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
